Mannkind CEO Trashes Sanofi Reps @ MP Securities Life Sciences Conference

Quote

Anonymous

Guest
Mannkind CEO Trashes Sanofi Reps @ MP Securities Life Sciences Conference. During his speech he basically said Sanofi Diabetes reps are not doing their job and your just "some Sanofi salesman". He said: "So these are peer-to-peer dinners and lunches and other kinds of meetings where they talk about Afrezza or doctors talk about their own experiences as opposed to some Sanofi salesman pitching it." Sucks when the CEO of your partner company tells people you cant do your job and they need doctors and DTC to actually do what your being paid for. Pathetic!
 






HO insider here. Before you either trash me or call me a liar, at least read my info. Sr. leadership is well aware of this and what is actively yet discretely being discussed is a wholesale reshuffling ( for lack of a better phrase) of Diabetes with significant cuts to current staff, regardless of performance( which ca no longer be measured as reliable or valid in a court of law) or tenure . The belief or perception is there are much " hungrier" contract reps available for a fraction of the cost of a SA rep that would be more highly motivated than the current salesforce. Attention is focused upon phasing this in between Sept.1-end of year.
I hope current leadership owns up to this so people can plan accordingly.
 








Anonymous said:
HO insider here. Before you either trash me or call me a liar, at least read my info. Sr. leadership is well aware of this and what is actively yet discretely being discussed is a wholesale reshuffling ( for lack of a better phrase) of Diabetes with significant cuts to current staff, regardless of performance( which ca no longer be measured as reliable or valid in a court of law) or tenure . The belief or perception is there are much " hungrier" contract reps available for a fraction of the cost of a SA rep that would be more highly motivated than the current salesforce. Attention is focused upon phasing this in between Sept.1-end of year.
I hope current leadership owns up to this so people can plan accordingly.
Click to expand...

Layoffs have always occurred in a period of decline of sales or a drop in stock price. HO insider's info seems to match all justifications of previous staff cuts. Since management have set precedent in the past with severance, it will probably accompany future downsizing.
 












Anonymous said:
Since Sanofi can't launch were all at risk. What horrible marketing failures in the last few years. Afrezza, Tuejo, Auviq, multaq. It goes on and on.
Click to expand...

Afrezza coming along just fine.

Toujeo has outpaced every recent launch - GLP1s Tanzeum and Trulicity lag well below Toujeo's launch. Even Farxiga was below the pace of Toujeo in the first three months.

AuviQ - there was NEVER a DTC campaign with TV ads for Epi pens and now Epi pens are marketed on TV. No accident that is because AuviQ has taken enough market share.

Multaq wasn't a marketing or sales failure - the product had too many post-marketing safety issues so the label add several updates with warnings. The cardiologists that really get Multaq have stayed with it the whole time.
 




Anonymous said:
Afrezza coming along just fine.

Toujeo has outpaced every recent launch - GLP1s Tanzeum and Trulicity lag well below Toujeo's launch. Even Farxiga was below the pace of Toujeo in the first three months.

AuviQ - there was NEVER a DTC campaign with TV ads for Epi pens and now Epi pens are marketed on TV. No accident that is because AuviQ has taken enough market share.

Multaq wasn't a marketing or sales failure - the product had too many post-marketing safety issues so the label add several updates with warnings. The cardiologists that really get Multaq have stayed with it the whole time.
Click to expand...



So Paris is pleased with how the Afrezza and Toujeo launches are going? If both products maintain their current trajectory upper management will be happy and reps will make bonus?

Is relative "launch performance" a good measurement for success? If so tell that to Paris and see if they agree.
 




Obvious you weren't there in the early days of Multaq. Multaq didn't have all the warnings at the start. That cluster took 3 years. There was virtually no LNL budget and it was launched on a shoe string budget. Plus they fucked reps on launch as it launched in July and your year end evaluation was based off of Aug and Sept numbers. Multaq wasn't a good drug. Just average in efficacy. Amino ruled and Sanofi got greedy at start with trying to get amio business and it backfired. Poor marketing for sure. Auviq was quite simply a totall mess. This was a texbook marketing failure. No docs ever heard of it or consumer. Had no coverage outside Northeast. Sanofi needed to price this below epipen to have any chance. No mother was going to spend 400.00 out of her pocket unless they were rich. The Auviq brand team and the leadership were incompetent. This launch showed firsthand if you have a great product that price and managed care is everything.Multaq and Auviq were epic marketing failures .
 




Anonymous said:
Afrezza coming along just fine.

Toujeo has outpaced every recent launch - GLP1s Tanzeum and Trulicity lag well below Toujeo's launch. Even Farxiga was below the pace of Toujeo in the first three months.

AuviQ - there was NEVER a DTC campaign with TV ads for Epi pens and now Epi pens are marketed on TV. No accident that is because AuviQ has taken enough market share.

Multaq wasn't a marketing or sales failure - the product had too many post-marketing safety issues so the label add several updates with warnings. The cardiologists that really get Multaq have stayed with it the whole time.
Click to expand...

Now you're saying the Toujeo launch is going well???!!! Quit fooling yourself here, man. Both Toujeo and Afrezza are performing way below expectations. Massive failures.
 








Anonymous said:
Yes all is well. Bye-bye troll! Happy 4th of July.
Click to expand...

Thanks for the 4th of July wishes. 'All is well' - keep saying that in front of the mirror every day right up to the point where you get laid off. We all know Toujeo and Afrezza are very far behind where they should be. Doesn't take a troll to know that.
 




Mannkind CEO mispoked. sannofe really does have the best repersentatives. Overheard him comment that compared to shuttle challenger launch with that teacher on board, this one is going great. roger that, challenger; throttle up!

We are NASA: Need Another Selling Approach
 




Top Bottom
Back
Quote